Mirtazapine
Product Images NDC 52959-902

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 52959-902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel-30 mg 500 Tablets Bottle (Mirtazapine Fig5)

Mirtazapine 30mg tablet packaging label from H.J. Harkins Company, Inc., showing product NDC 52959-902 with lot number MZT31QV and expiration date 07/12. The label references manufacturer Aurobindo in Dayton, NJ, and compares the product to Remeron. Includes instructions to follow doctor's directions or the outer label for dosage information, and mentions the tablet is reddish-brown. The label also displays multiple smaller identical labels for individual tablet bottles or containers.*

FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

Chemical structure diagram of mirtazapine showing its fused ring system including a pyridine and azepine ring, and a methyl group attached to a nitrogen atom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.